---
figid: PMC11751231__fphar-15-1483896-g010
figtitle: Schematic diagram of ginsenoside Rh2 inhibiting IL-6/JAK2/STAT3 signaling
  pathway in TNBC cells
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC11751231
filename: fphar-15-1483896-g010.jpg
figlink: /pmc/articles/PMC11751231/figure/F10/
number: F10
caption: A schematic diagram of ginsenoside Rh2 inhibiting IL-6/JAK2/STAT3 signaling
  pathway in TNBC cells. Cytokine IL-6 initiates the intracellular IL-6/JAK2/STAT3
  signaling pathway by binding to the receptor IL-6R on the surface of the cell membrane.
  Ginsenoside Rh2 can suppress the secretion of IL-6 by TNBC cells and thus inhibits
  the activation of IL-6/JAK2/STAT3. Furthermore, ginsenoside Rh2 also can induce
  the apoptosis of TNBC cells by decreasing the expression of anti-apoptotic proteins
  Bcl-2 and Bcl-xL. In addition, ginsenoside Rh2 can also inhibit the expression of
  protein kinases AMPK-alpha1 and PKA-Cα, which directly or indirectly regulates the
  JAK2/STAT3 pathway
papertitle: Ginsenoside Rh2 regulates triple-negative breast cancer proliferation
  and apoptosis via the IL-6/JAK2/STAT3 pathway
reftext: Rumeng Ding, et al. Front Pharmacol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphar.2024.1483896
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: ginsenoside Rh2 | triple-negative breast cancer | network Pharmacology |
  IL-6/JAK2/STAT3 pathway | apoptosis
automl_pathway: 0.9438744
figid_alias: PMC11751231__F10
figtype: Figure
redirect_from: /figures/PMC11751231__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11751231__fphar-15-1483896-g010.html
  '@type': Dataset
  description: A schematic diagram of ginsenoside Rh2 inhibiting IL-6/JAK2/STAT3 signaling
    pathway in TNBC cells. Cytokine IL-6 initiates the intracellular IL-6/JAK2/STAT3
    signaling pathway by binding to the receptor IL-6R on the surface of the cell
    membrane. Ginsenoside Rh2 can suppress the secretion of IL-6 by TNBC cells and
    thus inhibits the activation of IL-6/JAK2/STAT3. Furthermore, ginsenoside Rh2
    also can induce the apoptosis of TNBC cells by decreasing the expression of anti-apoptotic
    proteins Bcl-2 and Bcl-xL. In addition, ginsenoside Rh2 can also inhibit the expression
    of protein kinases AMPK-alpha1 and PKA-Cα, which directly or indirectly regulates
    the JAK2/STAT3 pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - jak2b
  - il6
  - il6r
  - stat3
  - chmp2a
  - PRKACA
  - JAK2
  - IL6
  - IL6R
  - STAT3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ADRA1D
  - BCL2
---
